Table 5.
Variable | HbA1c | Cholesterol | CVD risk |
---|---|---|---|
Intercept | 4.716 [4.663; 4.769] | 4.849 [4.822; 4.876] | − 0.658 [− 0.683; − 0.633] |
Degree (ref. other qualification) | − 0.171 [− 0.203; − 0.138] | − 0.033 [− 0.062; − 0.005] | − 0.127 [− 0.150; − 0.104] |
No qualification | 0.160 [0.136; 0.185] | 0.268 [0.247; 0.289] | 0.136 [0.119; 0.152] |
Year | 0.033 [0.032; 0.035] | − 0.026 [− 0.027; − 0.025] | − 0.015 [− 0.016; − 0.014] |
Degree x Year | 0.002 [− 0.000; 0.003] | 0.001 [− 0.001; 0.003] | 0.000 [− 0.001; 0.001] |
No qualification x Year | 0.000 [− 0.001; 0.002] | − 0.015 [− 0.017; − 0.014] | − 0.004 [− 0.005; − 0.003] |
HSE (ref. NHANES) | − 0.911 [− 1.017; − 0.805] | 0.432 [0.392; 0.472] | 0.139 [0.103; 0.174] |
SHS | v0.277 [− 0.406; − 0.148] | 0.537 [0.482; 0.592] | 0.252 [0.204; 0.300] |
n | 211251 | 235794 | 170684 |
m | 200 | 201 | 200 |
Coefficients and 99% confidence intervals. m and n: number of random-effect strata levels and sample size, respectively. HbA1c glycated haemoglobin, CVD cardiovascular disease. Log: logarithm